$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Inflammatory Pain Global Clinical Trials Review, H1, 2016
[Published by Global Data]

Published by Global Data: 16 Mar 2016 | 18181 | In Stock
Related Topics: Clinical Trials , Pain

Introduction

Inflammatory Pain Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2016" provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Inflammatory Pain Global Clinical Trials Review, H1, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Top Countries Contributing to Clinical Trials in Central and South America 13

    Clinical Trials by G7 Countries: Proportion of Inflammatory Pain to Central Nervous System Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Inflammatory Pain to Central Nervous System Clinical Trials 17

    Clinical Trials by Phase in E7 Countries 18

    Clinical Trials by Phase 19

    In Progress Trials by Phase 20

    Clinical Trials by Trial Status 21

    Clinical Trials by End Point Status 22

    Subjects Recruited Over a Period of Time 23

    Clinical Trials by Sponsor Type 24

    Prominent Sponsors 25

    Top Companies Participating in Inflammatory Pain Therapeutics Clinical Trials 26

    Prominent Drugs 28

    Clinical Trial Profile Snapshots 29

    Appendix 57

    Abbreviations 57

    Definitions 57

    Research Methodology 58

    Secondary Research 58

    About GlobalData 59

    Contact Us 59

    Disclaimer 59

    Source 60

List Of Tables
in Inflammatory Pain Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Tables

Inflammatory Pain Therapeutics, Global, Clinical Trials by Region, 2016* 5

Inflammatory Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Inflammatory Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Inflammatory Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9

Inflammatory Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Inflammatory Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Inflammatory Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12

Inflammatory Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13

Proportion of Inflammatory Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14

Inflammatory Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Inflammatory Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Inflammatory Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17

Inflammatory Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Inflammatory Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 19

Inflammatory Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20

Inflammatory Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Inflammatory Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Inflammatory Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Inflammatory Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24

Inflammatory Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Inflammatory Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Inflammatory Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List Of Figures, Charts and Diagrams
in Inflammatory Pain Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Figures

Inflammatory Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Inflammatory Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Inflammatory Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Inflammatory Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9

Inflammatory Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Proportion of Inflammatory Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14

Inflammatory Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Inflammatory Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Inflammatory Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17

Inflammatory Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Inflammatory Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19

Inflammatory Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20

Inflammatory Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

Inflammatory Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

Inflammatory Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

Inflammatory Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24

Inflammatory Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

Inflammatory Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

Inflammatory Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

GlobalData Methodology 58

Additional Details

Publisher

Global Data

Publisher Information

Reference

18181 | GDHC3292CTIDB

Number of Pages

60

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Inflammatory Bowel Disease Partnering 2010 to 2017
The Global Inflammatory Bowel Disease Partnering Terms and Agreements since 2010 report provides und...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval o...
01 Dec 2016 by GBI Research USD $4,995 More Info
Inflammatory Pain Global Clinical Trials Review, H2, 2016
Inflammatory Pain Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, ...
30 Nov 2016 by Global Data USD $2,500 More Info
Global Inflammatory Bowel Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Inflammatory Bowel Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Compet...
01 Jun 2016 by La Merie USD $560 More Info
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Compet...
01 Jun 2016 by La Merie USD $560 More Info
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015SummaryGlobal...
30 Dec 2015 by Global Data USD $2,500 More Info
Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015
Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologist...
01 Feb 2015 by FirstWord Pharma USD $5,995 More Info

This report is published by Global Data

Download Free Report Summary PDF

Inflammatory Pain Global Clinical Trials Review, H1, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...